Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer

Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer Publisher

Ashrafizadeh M¹ ; Bakhoda MR² ; Bahmanpour Z³ ; Ilkhani K³ ; Zarrabi A⁴ ; Makvandi P^{5, 6} ; Khan H⁷ ; Mazaheri S⁸ ; Darvish M⁹ ; Mirzaei H¹⁰

Source: Frontiers in Chemistry Published:2020

Abstract

Pancreatic cancer is the most lethal malignancy of the gastrointestinal tract. Due to its propensity for early local and distant spread, affected patients possess extremely poor prognosis. Currently applied treatments are not effective enough to eradicate all cancer cells, and minimize their migration. Besides, these treatments are associated with adverse effects on normal cells and organs. These therapies are not able to increase the overall survival rate of patients; hence, finding novel adjuvants or alternatives is so essential. Up to now, medicinal herbs were utilized for therapeutic goals. Herbal-based medicine, as traditional biotherapeutics, were employed for cancer treatment. Of them, apigenin, as a bioactive flavonoid that possesses numerous biological properties (e.g., anti-inflammatory and anti-oxidant effects), has shown substantial anticancer activity. It seems that apigenin is capable of suppressing the proliferation of cancer cells via the induction of cell cycle arrest and apoptosis. Besides, apigenin inhibits metastasis via down-regulation of matrix metalloproteinases and the Akt signaling pathway. In pancreatic cancer cells, apigenin sensitizes cells in chemotherapy, and affects molecular pathways such as the hypoxia inducible factor (HIF), vascular endothelial growth factor (VEGF), and glucose transporter-1 (GLUT-1). Herein, the biotherapeutic activity of apigenin and its mechanisms toward cancer cells are presented in the current review to shed some light on anti-tumor activity of apigenin in different cancers, with an emphasis on pancreatic cancer. © Copyright © 2020 Ashrafizadeh, Bakhoda, Bahmanpour, Ilkhani, Zarrabi, Makvandi, Khan, Mazaheri, Darvish and Mirzaei.

Related Docs

View other Related Docs

1. Apigenin in Cancer Therapy: Prevention of Genomic Instability and Anticancer Mechanisms, Clinical and Experimental Pharmacology and Physiology (2023)

2. Induction of Cancer Cell Death by Apigenin: A Review on Different Cell Death Pathways, Mini-Reviews in Medicinal Chemistry (2023)

3. The Influence of Apigenin on Cellular Responses to Radiation: From Protection to Sensitization, BioFactors (2025)

Experts (# of related papers)

View all Related Experts

Roja Rahimi (2)

Mohammad Abdollahi (2)

Style	Citing Format
MLA	Ashrafizadeh M, et al.. "Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer." Frontiers in Chemistry, vol. 8, no. , 2020, pp. -.
APA	Ashrafizadeh M, Bakhoda MR, Bahmanpour Z, Ilkhani K, Zarrabi A, Makvandi P, Khan H, Mazaheri S, Darvish M, Mirzaei H (2020). Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Frontiers in Chemistry, 8(), -.
Chicago	Ashrafizadeh M, Bakhoda MR, Bahmanpour Z, Ilkhani K, Zarrabi A, Makvandi P, Khan H, Mazaheri S, Darvish M, Mirzaei H. "Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer." Frontiers in Chemistry 8, no. (2020): -.
Harvard	Ashrafizadeh M et al. (2020) 'Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer', Frontiers in Chemistry, 8(), pp. -.
Vancouver	Ashrafizadeh M, Bakhoda MR, Bahmanpour Z, Ilkhani K, Zarrabi A, Makvandi P, et al.. Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Frontiers in Chemistry. 2020;8():-.
BibTex	@article{ author = {Ashrafizadeh M and Bakhoda MR and Bahmanpour Z and Ilkhani K and Zarrabi A and Makvandi P and Khan H and Mazaheri S and Darvish M and Mirzaei H}, title = {Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer}, journal = {Frontiers in Chemistry}, volume = {8}, number = {}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Ashrafizadeh M AU - Bakhoda MR AU - Bahmanpour Z AU - Ilkhani K AU - Zarrabi A AU - Makvandi P AU - Khan H AU - Mazaheri S AU - Darvish M AU - Mirzaei H TI - Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer JO - Frontiers in Chemistry VL - 8 IS - SP - EP - PY - 2020 ER -

Science Communicator Platform

Authors

Abstract